top of page


BioCryst Pharmaceuticals Inc.



chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api



Burn Rate (Qtr)


Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name




Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by



Company Profile

BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. At BioCryst, we are passionate about advancing novel therapeutics for patients with rare and serious diseases.

Recent Posts

See what the community is saying - click to see full post.

Upcoming September 2020 COVID-19 Therapeutic Catalyst Event

BCRX - NIAID Awards BioCryst New $44 Million Contract to Advance Development of Galidesivir

bottom of page